Discover what’s next in GU oncology at the 8th B2B GU Cancers Triad Meeting—Friday, November 13, in conjunction with SIU 2026 in Florence. From breakthrough research to practice-defining advances, this year’s programme dives into the strategies shaping the future of bladder, kidney, and prostate cancer care. The B2B GU Cancers Triad Meeting is included with your SIU 2026 registration.
See the Top 10 content on SIU Academy for the month of July, 2026.
You are invited to participate in an international, anonymous, web-based survey investigating current clinical practice patterns regarding bleeding risk assessment, transfusion strategies, and bleeding management during percutaneous nephrolithotomy (PCNL).
You are invited to take this survey designed to evaluate current practices, treatment preferences, and the factors influencing these preferences in the management of residual stones following urinary tract stone surgeries.
